Abeona Stock Buy Hold or Sell Recommendation


USD 3.96  0.08  2.06%   

Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Abeona Therapeutics is 'Strong Sell'. Macroaxis provides Abeona Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ABEO positions. The advice algorithm takes into account all of Abeona Therapeutics' available fundamental, technical, and predictive indicators you will find on this site.
The advice is provided from Abeona Therapeutics' buy-and-hold perspective. Please continue to Abeona Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Abeona and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Abeona Therapeutics.

Execute Abeona Therapeutics Buy or Sell Advice

The Abeona recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Abeona Therapeutics. Macroaxis does not own or have any residual interests in Abeona Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Abeona Therapeutics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Abeona TherapeuticsBuy Abeona Therapeutics
Strong Sell



Hype Condition


Current Valuation


Odds of Distress


Economic Sensitivity


Analyst Consensus


Financial Strenth (F Score)


Financial Leverage


Reporting Quality (M-Score)

For the selected time horizon Abeona Therapeutics has a Mean Deviation of 5.25, Semi Deviation of 6.1, Standard Deviation of 7.0, Variance of 49.05, Downside Variance of 39.87 and Semi Variance of 37.26
We provide trade advice to complement the prevailing expert consensus on Abeona Therapeutics. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Abeona Therapeutics is not overpriced, please confirm all Abeona Therapeutics fundamentals, including its ebitda, cash flow from operations, and the relationship between the price to book and total debt . Given that Abeona Therapeutics has a price to earning of 0.11 X, we suggest you to validate Abeona Therapeutics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Abeona Therapeutics Trading Alerts and Improvement Suggestions

Abeona Therapeutics has very high historical volatility over the last 90 days
The company reported the previous year's revenue of 3 M. Net Loss for the year was (84.94 M) with loss before overhead, payroll, taxes, and interest of (299 K).
Abeona Therapeutics currently holds about 20.1 M in cash with (65.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.38.
Abeona Therapeutics has a poor financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Purchase by Joseph Vazzano of 2500 shares of Abeona Therapeutics

Abeona Therapeutics Returns Distribution Density

The distribution of Abeona Therapeutics' historical returns is an attempt to chart the uncertainty of Abeona Therapeutics' future price movements. The chart of the probability distribution of Abeona Therapeutics stock daily returns describes the distribution of returns around its average expected value. We use Abeona Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Abeona Therapeutics returns is essential to provide solid investment advice for Abeona Therapeutics.
Mean Return0.26Value At Risk-8.98
Potential Upside12.24Standard Deviation7.00
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Abeona Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Abeona Therapeutics Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(860 K)(9.24 M)(6.31 M)(1.34 M)(4.15 M)(4.26 M)
Depreciation Amortization and Accretion741 K2.36 M8.68 M5.6 M4.46 M3.72 M
Net Cash Flow or Change in Cash and Cash Equivalents68.89 M(118.72 M)111.06 M(116.8 M)25.26 M27.25 M
Issuance Purchase of Equity Shares92.4 M5.48 M113.9 M178 K26.32 M35.03 M
Net Cash Flow from Financing92.4 M5.48 M113.9 M1.94 M24.86 M25.29 M
Net Cash Flow from Investing(860 K)(85.09 M)59.98 M(83.71 M)66.06 M71.28 M
Net Cash Flow from Operations(22.93 M)(39.11 M)(62.82 M)(35.02 M)(65.67 M)(67.39 M)
Share Based Compensation5.92 M8.87 M8.24 M8.19 M8.92 M8.23 M

Abeona Therapeutics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Abeona Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Abeona Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Abeona stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over NYSE Composite
Beta against NYSE Composite0.16
Overall volatility
Information ratio 0.019

Abeona Therapeutics Volatility Alert

Abeona Therapeutics is displaying above-average volatility over the selected time horizon. Investors should scrutinize Abeona Therapeutics independently to ensure intended market timing strategies are aligned with expectations about Abeona Therapeutics volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Abeona Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Abeona Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Abeona Therapeutics Fundamentals Vs Peers

Comparing Abeona Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Abeona Therapeutics' direct or indirect competition across all of the common fundamentals between Abeona Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Abeona Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Abeona Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Abeona Therapeutics by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Abeona Therapeutics to competition
FundamentalsAbeona TherapeuticsPeer Average
Return On Equity(1.79) %(0.31) %
Return On Asset(0.38) %(0.14) %
Operating Margin(10.92) %(5.51) %
Current Valuation55.57 M16.62 B
Shares Outstanding17.18 M571.82 M
Shares Owned by Insiders5.38 %10.09 %
Shares Owned by Institutions26.81 %39.21 %
Number of Shares Shorted1.07 M4.71 M
Price to Earning0.11 X28.72 X
Price to Book4.25 X9.51 X
Price to Sales14.86 X11.42 X
Revenue3 M9.43 B
Gross Profit(299 K)27.38 B
EBITDA(76.8 M)3.9 B
Net Income(84.94 M)570.98 M
Cash and Equivalents20.1 M2.7 B
Cash per Share3.38 X5.01 X
Total Debt8.54 M5.32 B
Debt to Equity0.42 %48.70 %
Current Ratio2.21 X2.16 X
Book Value Per Share2.01 X1.93 K
Cash Flow from Operations(65.67 M)971.22 M
Short Ratio1.66 X4.00 X
Earnings Per Share38.68 X3.12 X
Target Price21.33
Number of Employees9018.84 K
Market Capitalization64.58 M19.03 B
Total Asset79.59 M29.47 B
Retained Earnings(524.88 M)9.33 B
Working Capital25.43 M1.48 B
Current Asset31.95 M9.34 B
Current Liabilities6.51 M7.9 B
   Purchase by Joseph Vazzano of 2500 shares of Abeona Therapeutics [view details]

Abeona Therapeutics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Abeona . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Abeona Therapeutics Buy or Sell Advice

When is the right time to buy or sell Abeona Therapeutics? Buying financial instruments such as Abeona Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 (projected)
Receivables2.7 M2.91 M
Inventories174.6 K164.53 K

Use Investing Ideas to Build Portfolios

In addition to having Abeona Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Small Growth Thematic Idea Now

Small Growth
Small Growth Theme
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Abeona Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Abeona Therapeutics information on this page should be used as a complementary analysis to other Abeona Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Abeona Stock analysis

When running Abeona Therapeutics price analysis, check to measure Abeona Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abeona Therapeutics is operating at the current time. Most of Abeona Therapeutics' value examination focuses on studying past and present price action to predict the probability of Abeona Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abeona Therapeutics' price. Additionally, you may evaluate how the addition of Abeona Therapeutics to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
CEO Directory
Screen CEOs from public companies around the world
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Abeona Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abeona Therapeutics. If investors know Abeona will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abeona Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
64.6 M
Return On Assets
Return On Equity
The market value of Abeona Therapeutics is measured differently than its book value, which is the value of Abeona that is recorded on the company's balance sheet. Investors also form their own opinion of Abeona Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Abeona Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abeona Therapeutics' market value can be influenced by many factors that don't directly affect Abeona Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abeona Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Abeona Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abeona Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.